TickerGuard
Buy Day today: Neutral (59) Mixed market breadth · major macro event coming up
HIMS

Hims Hers Health Inc

Healthcare · Drug Manufacturers - Specialty & Generic

30.00$ -1.8% vs. previous close Closing price · As of: Aug 12, 2026

Statements

Segments

US companies must disclose in their mandatory reports how revenue breaks down across business segments, regions and product lines. We read that breakdown for you straight from the annual and quarterly reports (10-K and 10-Q) of Hims Hers Health Inc (HIMS). It shows which part of the business is growing — and which one is holding it back.

Revenue by region

Revenue by region — HIMS
Segment 2023 2024 2025
United States Revenue $854.5M 98.0% $1.45B 98.2% · +69.7% $2.21B 94.3% · +52.7%
Rest of the World Revenue $17.5M 2.0% $26.8M 1.8% · +53.3% $134.0M 5.7% · +399.2%

Large figure: segment revenue. Below it the share of revenue in that period and the change against the prior year.

Segment and region names are the ones the company itself uses and are shown as reported. Change and share refer to revenue.

Data as of: August 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Segment figures: SEC EDGAR (10-K/10-Q reports)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?